Allergan (AGN) had its price target increased by Citigroup (C) to $124 as the company’s core business continues to grow at double digit rates. Shares are lower by about 2.4 percent.
Thanks for checking us out. Please take a look at the rest of our videos and articles.
To stay in the loop, bookmark our homepage.